|
1
|
Richette P and Bardin T: Gout. Lancet.
375:318–328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuo CF, Grainge MJ, Zhang W and Doherty M:
Global epidemiology of gout: Prevalence, incidence and risk
factors. Nat Rev Rheumatol. 11:649–662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang X, Yang X, Wang M, Li X, Xia Q, Xu
S, Xu J, Cai G, Wang L, Xin L, et al: Association between SLC2A9
(GLUT9) gene polymorphisms and gout susceptibility: An updated
meta-analysis. Rheumatol Int. 36:1157–1165. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsuo H, Takada T, Ichida K, Nakamura T,
Nakayama A, Ikebuchi Y, Ito K, Kusanagi Y, Chiba T, Tadokoro S, et
al: Common defects of ABCG2, a high-capacity urate exporter, cause
gout: A function-based genetic analysis in a Japanese population.
Sci Transl Med. 1:5ra112009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan PK, Farrar JE, Gaucher EA and Miner
JN: Coevolution of URAT1 and uricase during primate evolution:
Implications for serum urate homeostasis and gout. Mol Biol Evol.
33:2193–2200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pennisi E: Cell biology. Lengthy RNAs earn
respect as cellular players. Science. 344:10722014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang C, Wang L, Ding Y, Lu X, Zhang G,
Yang J, Zheng H, Wang H, Jiang Y and Xu L: LncRNA structural
characteristics in epigenetic regulation. Int J Mol Sci.
18:E26592017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saha P, Verma S, Pathak RU and Mishra RK:
Long Noncoding RNAs in mammalian development and diseases. Adv Exp
Med Biol. 1008:155–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwok ZH and Tay Y: Long noncoding RNAs:
lincs between human health and disease. Biochem Soc Trans.
45:805–812. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khanna D, Khanna PP, Fitzgerald JD, Singh
MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, et
al: 2012 American college of rheumatology guidelines for management
of gout. Part 2: Therapy and anti-inflammatory prophylaxis of acute
gouty arthritis. Arthritis Care Res (Hoboken). 64:1447–1461. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gomez JA, Wapinski OL, Yang YW, Bureau JF,
Gopinath S, Monack DM, Chang HY, Brahic M and Kirkegaard K: The
NeST Long ncRNA controls microbial susceptibility and epigenetic
activation of the interferon-gamma locus. Cell. 152:743–754. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lai F, Orom UA, Cesaroni M, Beringer M,
Taatjes DJ, Blobel GA and Shiekhattar R: Activating RNAs associate
with Mediator to enhance chromatin architecture and transcription.
Nature. 494:497–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
The Gene Ontology Consortium: Expansion of
the Gene Ontology knowledgebase and resources. Nucleic Acids Res.
45(D1): D331–D338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalliolias GD and Ivashkiv LB: TNF
biology, pathogenic mechanisms and emerging therapeutic strategies.
Nat Rev Rheumatol. 12:49–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shapiro F: Bone development and its
relation to fracture repair. The role of mesenchymal osteoblasts
and surface osteoblasts. Eur Cell Mater. 15:53–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qing YF, Zhang QB and Zhou JG: Innate
immunity functional gene polymorphisms and gout susceptibility.
Gene. 524:412–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mattick JS: Non-coding RNAs: The
architects of eukaryotic complexity. EMBO Rep. 2:986–991. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stachurska A, Zorro MM, van der Sijde MR
and Withoff S: Small and long regulatory RNAs in the immune system
and immune diseases. Front Immunol. 5:5132014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo Q, Li X, Xu C, Zeng L, Ye J, Guo Y,
Huang Z and Li J: Integrative analysis of long non-coding RNAs and
messenger RNA expression profiles in systemic lupus erythematosus.
Mol Med Rep. 17:3489–3496. 2018.PubMed/NCBI
|
|
23
|
Li LJ, Zhao W, Tao SS, Li J, Xu SZ, Wang
JB, Leng RX, Fan YG, Pan HF and Ye DQ: Comprehensive long
non-coding RNA expression profiling reveals their potential roles
in systemic lupus erythematosus. Cell Immunol. 319:17–27. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S,
Jiang Z, Xu J, Liu Q and Cao X: The STAT3-binding long noncoding
RNA lnc-DC controls human dendritic cell differentiation. Science.
344:310–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu GC, Li J, Leng RX, Li XP, Li XM, Wang
DG, Pan HF and Ye DQ: Identification of long non-coding RNAs GAS5,
linc0597 and lnc-DC in plasma as novel biomarkers for systemic
lupus erythematosus. Oncotarget. 8:23650–23663. 2017.PubMed/NCBI
|
|
26
|
Pan F, Zhu L, Lv H and Pei C: Quercetin
promotes the apoptosis of fibroblast-like synoviocytes in
rheumatoid arthritis by upregulating lncRNA MALAT1. Int J Mol Med.
38:1507–1514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Spurlock CF III, Tossberg JT, Matlock BK,
Olsen NJ and Aune TM: Methotrexate inhibits NF-κB activity via long
intergenic (noncoding) RNA-p21 induction. Arthritis Rheumatol.
66:2947–2957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Q, Zhang X, Dai L, Hu X, Zhu J, Li L,
Zhou C and Ao Y: Long noncoding RNA related to cartilage injury
promotes chondrocyte extracellular matrix degradation in
osteoarthritis. Arthritis Rheumatol. 66:969–978. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang CL, Peng JP and Chen XD: LncRNA-CIR
promotes articular cartilage degeneration in osteoarthritis by
regulating autophagy. Biochem Biophys Res Commun. 505:692–698.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mount DB: The kidney in hyperuricemia and
gout. Curr Opin Nephrol Hypertens. 22:216–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prasad Sah OS and Qing YX: Associations
between hyperuricemia and chronic kidney disease: A Review.
Nephrourol Mon. 7:e272332015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Georganas C, Liu H, Perlman H, Hoffmann A,
Thimmapaya B and Pope RM: Regulation of IL-6 and IL-8 expression in
rheumatoid arthritis synovial fibroblasts: The dominant role for
NF-kappa B but not C/EBP beta or c-Jun. J Immunol. 165:7199–7206.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
De Benedetti F, Pignatti P, Bernasconi S,
Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S,
Fantini F and Martini A: Interleukin 8 and monocyte chemoattractant
protein-1 in patients with juvenile rheumatoid arthritis. Relation
to onset types, disease activity, and synovial fluid leukocytes. J
Rheumatol. 26:425–431. 1999.PubMed/NCBI
|
|
34
|
Lun SW, Wong CK, Tam LS, Li EK and Lam CW:
Decreased ex vivo produxtion of TNF-alpha and IL-8 by peripheral
blood cells of patients with rheumatoid arthritis after infliximab
therapy. Int Immuno pharmacol. 7:1668–1677. 2007. View Article : Google Scholar
|
|
35
|
König A, Krenn V, Gillitzer R, Glöckner J,
Janssen E, Gohlke F, Eulert J and Müller-Hermelink HK: Inflammatory
infiltrate and interleukin-8 expression in the synovium of
psoriatic arthritis-an immunohistochemical and mRNA analysis.
Rheumatol Int. 17:159–168. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Biasi D, Carletto A, Caramaschi P,
Bellavite P, Maleknia T, Scambi C, Favalli N and Bambara LM:
Neutrophil functions and IL-8 in psoriatic arthritis and in
cutaneous psoriasis. Inflammation. 22:533–543. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsai YC and Tsai TF: Anti-interleukin and
interleukin therapies for psoriasis: Current evidence and clinical
usefulness. Ther Adv Musculoskelet Dis. 9:277–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kienhorst LB, van Lochem E, Kievit W,
Dalbeth N, Merriman ME, Phipps-Green A, Loof A, van Heerde W,
Vermeulen S, Stamp LK, et al: Gout is a chronic inflammatory
disease in which high levels of interleukin-8 (CXCL8),
myeloid-related protein 8/myeloid-related protein 14 complex, and
an altered proteome are associated with diabetes mellitus and
cardiovascular disease. Arthritis Rheumatol. 67:3303–3313. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hachicha M, Naccache PH and McColl SR:
Inflammatory microcrystals differentially regulate the secretion of
macrophage inflammatory protein 1 and interleukin 8 by human
neutrophils: A possible mechanism of neutrophil recruitment to
sites of inflammation in synovitis. J Exp Med. 182:2019–2025. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nishimura A, Akahoshi T, Takahashi M,
Takagishi K, Itoman M, Kondo H, Takahashi Y, Yokoi K, Mukaida N and
Matsushima K: Attenuation of monosodium urate crystal-induced
arthritis in rabbits by a neutralizing antibody against
interleukin-8. J Leukoc Biol. 62:444–449. 1997. View Article : Google Scholar : PubMed/NCBI
|
